lipotropic

(redirected from lipotropism)
Also found in: Thesaurus, Medical, Encyclopedia.

lip·o·trop·ic

 (lĭp′ō-trŏp′ĭk, -trō′pĭk, lī′pō-)
adj.
1. Preventing abnormal or excessive accumulation of fat in the liver.
2. Having an affinity for lipids.

li·pot′ro·py (lĭ-pŏt′rə-pē, lī-), li·pot′ro·pism n.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

lipotropic

(ˌlɪpəʊˈtrɒpɪk)
adj
(Biochemistry) (of a substance) increasing the utilization of fat by the tissues
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014

lip•o•trop•ic

(ˌlɪp əˈtrɒp ɪk, -ˈtroʊ pɪk, ˌlaɪ pə-)

adj.
having an affinity for lipids and thus preventing or correcting excess accumulation of fat in the liver.
[1930–35]
li•pot•ro•pism (lɪˈpɒ trəˌpɪz əm, laɪ-) n.
Random House Kernerman Webster's College Dictionary, © 2010 K Dictionaries Ltd. Copyright 2005, 1997, 1991 by Random House, Inc. All rights reserved.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Adj.1.lipotropic - having an affinity for lipids
chemical science, chemistry - the science of matter; the branch of the natural sciences dealing with the composition of substances and their properties and reactions
oleophilic - having a strong affinity for oils rather than water
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
References in periodicals archive ?
Second-generation DES (G2-DES), represented by zotarolimus-eluting stents and cobalt-chromium everolimus-eluting stents, exhibit improved stability and lipotropism of eluting drugs compared with first-generation DES (G1-DES).[sup][1],[2],[3] Furthermore, improvements in the polymer biocompatibility coupled with a well-proportioned and slim frame help to reduce endothelial damage and proliferation.[sup][1],[2],[3],[4],[5],[6],[7] Many trials demonstrate that the improved properties of G2-DES results in therapeutic benefits for stable coronary artery disease (SCAD) patients.[sup][1],[8],[9],[10],[11],[12],[13],[14],[15] A recent network meta-analysis by Windecker et al .